Compugen Research Development vs Ebitda Analysis

CGEN Stock  USD 1.60  0.03  1.84%   
Compugen financial indicator trend analysis is way more than just evaluating Compugen prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Compugen is a good investment. Please check the relationship between Compugen Research Development and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

Research Development vs Ebitda

Research Development vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Compugen Research Development account and Ebitda. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Compugen's Research Development and Ebitda is -0.65. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Ebitda in the same time period over historical financial statements of Compugen, assuming nothing else is changed. The correlation between historical values of Compugen's Research Development and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Compugen are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Research Development i.e., Compugen's Research Development and Ebitda go up and down completely randomly.

Correlation Coefficient

-0.65
Relationship DirectionNegative 
Relationship StrengthWeak

Research Development

Ebitda

Most indicators from Compugen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Compugen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.As of the 11th of December 2024, Tax Provision is likely to grow to about 9.4 M, while Selling General Administrative is likely to drop about 6.6 M.
 2021 2022 2023 2024 (projected)
Net Interest Income871K1.7M3.2M3.4M
Interest Income894K1.7M3.0M3.1M

Compugen fundamental ratios Correlations

0.610.540.950.34-0.03-0.630.440.050.42-0.080.90.240.70.790.18-0.710.80.360.420.90.79-0.20.060.660.63
0.610.890.480.250.41-0.890.61-0.34-0.140.160.530.610.920.770.57-0.780.750.750.660.820.77-0.170.410.950.66
0.540.890.370.070.31-0.790.55-0.230.030.170.320.850.860.580.81-0.610.560.940.710.780.58-0.110.690.890.35
0.950.480.370.44-0.13-0.50.340.160.53-0.140.940.070.580.67-0.04-0.640.70.160.350.840.66-0.3-0.140.530.61
0.340.250.070.44-0.42-0.330.320.450.07-0.30.43-0.070.30.36-0.28-0.060.41-0.130.640.320.36-0.52-0.50.230.29
-0.030.410.31-0.13-0.42-0.270.14-0.99-0.440.59-0.010.220.280.240.34-0.650.140.34-0.090.140.210.080.380.430.49
-0.63-0.89-0.79-0.5-0.33-0.27-0.510.21-0.02-0.24-0.54-0.5-0.98-0.89-0.520.68-0.89-0.68-0.64-0.76-0.890.1-0.3-0.95-0.6
0.440.610.550.340.320.14-0.51-0.140.00.080.340.250.470.540.12-0.40.540.330.440.440.52-0.340.060.540.36
0.05-0.34-0.230.160.45-0.990.21-0.140.46-0.590.03-0.14-0.2-0.22-0.260.61-0.12-0.260.17-0.07-0.19-0.09-0.32-0.35-0.47
0.42-0.140.030.530.07-0.44-0.020.00.460.070.28-0.020.10.07-0.160.050.13-0.080.030.220.09-0.32-0.11-0.02-0.11
-0.080.160.17-0.14-0.30.59-0.240.08-0.590.07-0.130.050.210.180.17-0.290.140.18-0.1-0.060.18-0.010.180.280.36
0.90.530.320.940.43-0.01-0.540.340.030.28-0.13-0.080.580.72-0.07-0.720.740.110.230.810.72-0.09-0.210.560.77
0.240.610.850.07-0.070.22-0.50.25-0.14-0.020.05-0.080.60.220.89-0.290.190.920.720.520.21-0.140.850.61-0.05
0.70.920.860.580.30.28-0.980.47-0.20.10.210.580.60.840.6-0.740.840.760.690.850.85-0.130.40.970.6
0.790.770.580.670.360.24-0.890.54-0.220.070.180.720.220.840.23-0.730.990.420.450.741.0-0.150.040.820.73
0.180.570.81-0.04-0.280.34-0.520.12-0.26-0.160.17-0.070.890.60.23-0.340.20.960.490.460.250.30.930.620.02
-0.71-0.78-0.61-0.64-0.06-0.650.68-0.40.610.05-0.29-0.72-0.29-0.74-0.73-0.34-0.69-0.49-0.28-0.8-0.720.07-0.25-0.81-0.86
0.80.750.560.70.410.14-0.890.54-0.120.130.140.740.190.840.990.2-0.690.390.470.740.99-0.150.00.80.71
0.360.750.940.16-0.130.34-0.680.33-0.26-0.080.180.110.920.760.420.96-0.490.390.620.640.420.110.860.780.18
0.420.660.710.350.64-0.09-0.640.440.170.03-0.10.230.720.690.450.49-0.280.470.620.610.44-0.490.30.640.19
0.90.820.780.840.320.14-0.760.44-0.070.22-0.060.810.520.850.740.46-0.80.740.640.610.74-0.150.320.840.64
0.790.770.580.660.360.21-0.890.52-0.190.090.180.720.210.851.00.25-0.720.990.420.440.74-0.10.040.820.73
-0.2-0.17-0.11-0.3-0.520.080.1-0.34-0.09-0.32-0.01-0.09-0.14-0.13-0.150.30.07-0.150.11-0.49-0.15-0.10.27-0.1-0.09
0.060.410.69-0.14-0.50.38-0.30.06-0.32-0.110.18-0.210.850.40.040.93-0.250.00.860.30.320.040.270.43-0.12
0.660.950.890.530.230.43-0.950.54-0.35-0.020.280.560.610.970.820.62-0.810.80.780.640.840.82-0.10.430.66
0.630.660.350.610.290.49-0.60.36-0.47-0.110.360.77-0.050.60.730.02-0.860.710.180.190.640.73-0.09-0.120.66
Click cells to compare fundamentals

Compugen Account Relationship Matchups

Compugen fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets53.8M138.3M132.2M94.2M121.3M70.8M
Other Current Liab4.4M7.8M10.9M8.9M11.0M11.5M
Total Current Liabilities6.8M10.5M17.1M11.9M26.3M27.6M
Total Stockholder Equity38.3M119.8M106.7M77.7M65.6M57.7M
Property Plant And Equipment Net5.6M4.5M3.9M3.4M2.5M3.3M
Net Debt(40.3M)(4.0M)(5.1M)(9.1M)(12.5M)(13.2M)
Retained Earnings(358.2M)(387.9M)(422.1M)(455.8M)(474.5M)(450.8M)
Accounts Payable1.1M1.4M4.6M1.8M3.5M1.9M
Cash43.9M7.1M7.8M11.1M13.9M26.5M
Non Current Assets Total8.8M9.2M8.9M8.1M6.8M10.6M
Non Currrent Assets Other3.2M4.7M5.0M4.7M4.2M3.9M
Cash And Short Term Investments43.9M124.4M117.8M83.7M50.7M48.3M
Net Receivables1.1M2.2M188K317K61.3M64.4M
Common Stock Shares Outstanding63.6M79.6M84.2M86.6M87.6M47.3M
Liabilities And Stockholders Equity53.8M138.3M132.2M94.2M121.3M70.8M
Non Current Liabilities Total8.6M8.0M8.4M4.6M29.5M31.0M
Inventory(780K)(119.3M)(110.0M)(72.6M)(65.4M)(62.1M)
Other Stockholder Equity396.3M507.4M528.5M533.2M539.8M292.4M
Total Liab15.4M18.5M25.5M16.5M55.8M58.6M
Property Plant And Equipment Gross5.6M4.5M3.9M3.4M7.9M8.3M
Total Current Assets45M129.1M123.2M86.1M114.6M120.3M
Accumulated Other Comprehensive Income(6.3M)(4.9M)(5.4M)2K2.3K2.4K
Common Stock187K231K239K240K247K133.4K
Other Liab5.6M5.5M6.4M3.3M3.8M4.6M
Other Assets3.2M4.7M5.0M4.7M5.4M5.7M
Short Term Investments34.0M116.6M109.2M72.3M36.8M29.0M
Other Current Assets780K2.5M5.3M2.1M2.6M4.9M
Property Plant Equipment5.6M4.5M3.9M3.4M3.9M3.4M
Net Tangible Assets38.3M119.8M106.7M77.7M89.3M77.0M
Net Invested Capital38.3M119.8M106.7M77.7M65.6M74.6M
Net Working Capital38.2M118.6M106.1M74.2M88.3M76.5M
Capital Stock187K231K239K240K247K239.8K

Pair Trading with Compugen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Compugen Stock

  0.85ME 23Andme HoldingPairCorr
  0.8VALN Valneva SE ADRPairCorr

Moving against Compugen Stock

  0.81BMY Bristol Myers SquibbPairCorr
  0.57ESPR Esperion TherapeuticsPairCorr
  0.57IKT Inhibikase TherapeuticsPairCorr
  0.51XCUR Exicure Upward RallyPairCorr
  0.48DYAI Dyadic InternationalPairCorr
The ability to find closely correlated positions to Compugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugen to buy it.
The correlation of Compugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Compugen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.03
Revenue Per Share
0.48
Quarterly Revenue Growth
3.461
Return On Assets
(0.03)
Return On Equity
(0.16)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.